Blood Treatment Apparatus Dynamic TMP Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current blood treatment apparatuses face challenges in efficiently managing high convective exchange during hemofiltration or hemodiafiltration, particularly in maintaining patient comfort while controlling weight loss, plasma conductivity, and sodium concentration, with existing methods being limited in their ability to rapidly set optimal transmembrane pressure (TMP) values.

Innovation Solution

An apparatus with sensor means to monitor blood volume, ultrafiltration flow rate, weight loss rate, plasma conductivity, and infusion flow rate, coupled with a control unit that calculates and adjusts conductivity, sodium concentration, and TMP values in real-time to optimize fluid exchange and patient comfort during treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If TMP is set to maximise ultrafiltration flow rate, then convective exchange capacity is improved, but patient comfort deteriorates

Engineering Contradiction:
Improveconvective exchange capacityVSAvoidpatient comfort
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent implements dynamic control of TMP throughout the treatment session, transitioning from higher initial TMP values to lower subsequent values. This dynamic adjustment allows maximization of convective exchange when needed while maintaining patient comfort as treatment progresses, resolving the contradiction between productivity and comfort

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The treatment is divided into multiple phases with different TMP settings. The control unit implements periodic adjustment of TMP, applying higher values during phases requiring maximum convective exchange and lower values during phases prioritizing patient comfort, thus balancing both requirements

Inventive Principle:
Principle #19Periodic action

2Productivity

If multiple parameters are controlled simultaneously, then treatment efficacy is improved, but device complexity increases

Engineering Contradiction:
Improvetreatment efficacyVSAvoidcontrol system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The control unit continuously monitors multiple parameters (ultrafiltration flow rate, weight loss rate, blood volume, plasma conductivity, sodium concentration) and automatically adjusts TMP and other control variables based on feedback from sensors. This closed-loop control achieves comprehensive parameter management while simplifying operator intervention

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The control unit serves multiple functions simultaneously: monitoring various physiological parameters, calculating optimal TMP values, adjusting pump speeds, and coordinating treatment phases. This multi-functional integration reduces overall system complexity despite managing multiple parameters

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Loss of time

If TMP setting sequence is accelerated, then treatment time is reduced, but safety may be compromised

Engineering Contradiction:
ImproveTMP setting timeVSAvoidtreatment safety
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The control unit pre-calculates optimal TMP values based on patient-specific parameters and treatment goals before initiating treatment. This preliminary setup enables rapid TMP adjustment during treatment while ensuring safety through pre-validated parameter selections

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system incorporates safety margins and validated TMP ranges in the pre-programmed treatment protocol. Even when accelerating TMP adjustments, the control unit ensures values remain within clinically proven safe boundaries, cushioning against potential safety risks

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The apparatus ensures efficient convective exchange, maintains patient comfort by dynamically controlling fluid and electrolyte balance, and rapidly sets optimal TMP values to enhance treatment efficacy.

Implementation Method 1

at least one treatment unit (for example a dialyser or a filter or ultrafilter or a plasma filter or a filtering unit of another type) having a semipermeable membrane which separates the treatment unit into two chambers

Methodology Applied
Scientific EffectSemipermeable membrane separation: Semipermeable Membrane

Implementation Method 2

setting the TMP value at a level which is such as to maximise the ultrafiltration flow rate and consequently the volume of fluid infused into the patient

Methodology Applied
Scientific EffectUltrafiltration: Reverse Osmosis

Implementation Method 3

maximise the convective exchange through the membrane and thus the purification of the blood from undesired particles

Methodology Applied
Scientific EffectConvective exchange: Convection

Data Source

PatentUS9199027B2Apparatus for extracorporeal blood treatment
Publication Date: 2015.12.01 GAMBRO DASCO SPA
  • US9199027B2 patent drawing
  • US9199027B2 patent drawing
  • US9199027B2 patent drawing

AI summary

An apparatus for extracorporeal blood treatment is described, including a treatment unit, an extracorporeal blood circuit, an infusion line of a replacement fluid, a dialysis line connected in inlet to the second chamber, and a fluid evacuation line; sensors for determining a first parameter relating to a patient's blood volume (BV %) a second parameter relating to an ultrafiltration flow rate (UFR) or to a patient's weight loss rate (WLR), a third parameter (Cd, Na) relating to a conductivity or concentration of a liquid crossing the dialysis line and/or the infusion line, and a fourth parameter relating to an infusion flow rate (QINF), and a control unit for performing a control procedure.